InvestorsHub Logo
Followers 34
Posts 3499
Boards Moderated 0
Alias Born 10/27/2003

Re: falconer66a post# 356128

Saturday, 04/02/2022 3:47:05 PM

Saturday, April 02, 2022 3:47:05 PM

Post# of 468779

Importantly, patients receiving Lomecel-B were not reported to develop a serious side-effect called amyloid-related imaging abnormalities (ARIA) as assessed by magnetic resonance imaging (MRI). Other classes of Alzheimer’s drugs being tested have been reported to cause ARIA.



Whoa there, lets do our reading....

https://investors.longeveron.com/news/News/news-details/2022/Longeveron-Publishes-Peer-Reviewed-Study-of-Phase-1-Trial-Results-of-Lomecel-B-for-Alzheimers-Disease-in-Alzheimers--Dementia-The-Journal-of-the-Alzheimers-Association/default.aspx
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News